PL1667666T3 - Farmaceutyczna kompozycja zawierająca fenofibrat oraz sposób jej wytwarzania - Google Patents
Farmaceutyczna kompozycja zawierająca fenofibrat oraz sposób jej wytwarzaniaInfo
- Publication number
- PL1667666T3 PL1667666T3 PL04769636T PL04769636T PL1667666T3 PL 1667666 T3 PL1667666 T3 PL 1667666T3 PL 04769636 T PL04769636 T PL 04769636T PL 04769636 T PL04769636 T PL 04769636T PL 1667666 T3 PL1667666 T3 PL 1667666T3
- Authority
- PL
- Poland
- Prior art keywords
- fenofibrate
- composition
- preparation
- composition containing
- surfactant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/501—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/677,861 US7863331B2 (en) | 1999-07-09 | 2003-10-03 | Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
EP04769636A EP1667666B9 (en) | 2003-10-03 | 2004-10-01 | Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
PCT/IB2004/003354 WO2005032526A1 (en) | 2003-10-03 | 2004-10-01 | Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1667666T3 true PL1667666T3 (pl) | 2009-09-30 |
Family
ID=34422141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL04769636T PL1667666T3 (pl) | 2003-10-03 | 2004-10-01 | Farmaceutyczna kompozycja zawierająca fenofibrat oraz sposób jej wytwarzania |
Country Status (23)
Country | Link |
---|---|
US (2) | US7863331B2 (pl) |
EP (2) | EP2000133A3 (pl) |
JP (1) | JP5490354B2 (pl) |
KR (1) | KR101150235B1 (pl) |
CN (1) | CN100544712C (pl) |
AT (1) | ATE428408T1 (pl) |
AU (1) | AU2004277757B2 (pl) |
BR (1) | BRPI0414860B8 (pl) |
CA (1) | CA2540235C (pl) |
CY (1) | CY1109929T1 (pl) |
DE (1) | DE602004020641D1 (pl) |
DK (1) | DK1667666T3 (pl) |
ES (1) | ES2324670T3 (pl) |
HK (1) | HK1084895A1 (pl) |
IL (1) | IL174660A (pl) |
MX (1) | MXPA06003656A (pl) |
NO (1) | NO335933B1 (pl) |
NZ (1) | NZ546692A (pl) |
PL (1) | PL1667666T3 (pl) |
PT (1) | PT1667666E (pl) |
SI (1) | SI1667666T1 (pl) |
WO (1) | WO2005032526A1 (pl) |
ZA (1) | ZA200603504B (pl) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7863331B2 (en) * | 1999-07-09 | 2011-01-04 | Ethypharm | Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
FR2795961B1 (fr) * | 1999-07-09 | 2004-05-28 | Ethypharm Lab Prod Ethiques | Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation |
US20080051411A1 (en) * | 2002-12-17 | 2008-02-28 | Cink Russell D | Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof |
CA2510261A1 (en) * | 2002-12-17 | 2004-07-01 | Abbott Gmbh & Co. Kg | Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof |
US8062664B2 (en) * | 2003-11-12 | 2011-11-22 | Abbott Laboratories | Process for preparing formulations of lipid-regulating drugs |
US8026281B2 (en) * | 2004-10-14 | 2011-09-27 | Lupin Atlantis Holdings, S.A. | Treating metabolic syndrome with fenofibrate |
MX2007009571A (es) * | 2005-02-25 | 2007-09-21 | Hoffmann La Roche | Tabletas con dispersion mejorada de la sustancia del farmaco. |
RU2009102262A (ru) * | 2006-06-26 | 2010-08-10 | Мьючуал Фармасьютикал Компани, Инк. (Us) | Композиции активного агента, способы их получения и способы применения |
JP5186159B2 (ja) * | 2006-08-31 | 2013-04-17 | あすか製薬株式会社 | フェノフィブラート含有組成物 |
JP2013047282A (ja) * | 2006-08-31 | 2013-03-07 | Aska Pharmaceutical Co Ltd | フェノフィブラート含有組成物 |
US20100159010A1 (en) * | 2008-12-24 | 2010-06-24 | Mutual Pharmaceutical Company, Inc. | Active Agent Formulations, Methods of Making, and Methods of Use |
FR2940118B1 (fr) * | 2008-12-24 | 2013-08-09 | Ethypharm Sa | Formulation pharmaceutique de fenofibrate nanonise |
WO2010078429A1 (en) * | 2008-12-30 | 2010-07-08 | Impax Laboratories, Inc. | Pharmaceutical dosage forms and methods of manufacturing same |
JPWO2010092925A1 (ja) * | 2009-02-12 | 2012-08-16 | あすか製薬株式会社 | 固体分散体とその医薬組成物、並びにそれらの製造方法 |
CN101502497B (zh) * | 2009-03-06 | 2010-11-10 | 安徽省药物研究所 | 非诺贝特药物组合物 |
US20110217369A1 (en) * | 2009-09-03 | 2011-09-08 | Ranbaxy Laboratories Limited | Fenofibrate compositions |
WO2013169577A1 (en) * | 2012-05-07 | 2013-11-14 | Bristol-Myers Squibb Company | Oral solid dosage formulation of 1,1-dimethylethyl [(1s)-1-{[(2s,4r)-4-(7-chloro-4methoxyisoquinolin-1-yloxy)-2-({(1r,2s)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}carbamoyl)pyrrolidin-1-yl]carbonyl}-2,2-dimethylpropyl]carbamate |
US8722083B2 (en) * | 2012-06-25 | 2014-05-13 | Mylan, Inc. | Fenofibrate formulation |
CA2877901A1 (en) * | 2012-06-25 | 2014-01-03 | Mylan, Inc. | Fenofibrate formulation |
US9439860B2 (en) | 2012-06-25 | 2016-09-13 | Mylan, Inc. | Fenofibrate formulation |
WO2014091318A1 (en) | 2012-12-11 | 2014-06-19 | Lupin Atlantis Holdings, S.A. | Reduced dose pharmaceutical compositions of fenofibrate |
WO2017027806A1 (en) | 2015-08-13 | 2017-02-16 | Coty Inc. | Formulation and method for promoting cutaneous uptake of molecular oxygen by skin |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4058552A (en) | 1969-01-31 | 1977-11-15 | Orchimed Sa | Esters of p-carbonylphenoxy-isobutyric acids |
CH543472A (fr) | 1969-01-31 | 1973-10-31 | Orchimed Sa | Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques |
GB1579818A (en) | 1977-06-07 | 1980-11-26 | Yamanouchi Pharma Co Ltd | Nifedipine-containing solid preparation composition |
DE2966564D1 (en) | 1978-11-20 | 1984-02-23 | American Home Prod | Therapeutic compositions with enhanced bioavailability and process for their preparation |
US4344934A (en) | 1978-11-20 | 1982-08-17 | American Home Products Corporation | Therapeutic compositions with enhanced bioavailability |
FR2494112B1 (pl) | 1980-11-19 | 1986-01-10 | Laruelle Claude | |
GB8414221D0 (en) | 1984-06-04 | 1984-07-11 | Sterwin Ag | Unit dosage form |
GB8414220D0 (en) | 1984-06-04 | 1984-07-11 | Sterwin Ag | Medicaments in unit dose form |
FR2602423B1 (fr) * | 1986-08-08 | 1989-05-05 | Ethypharm Sa | Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede |
US4752470A (en) | 1986-11-24 | 1988-06-21 | Mehta Atul M | Controlled release indomethacin |
FR2627696B1 (fr) * | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
DE59005781D1 (de) | 1990-07-02 | 1994-06-23 | Boehringer Mannheim Gmbh | Verfahren zur herstellung geformter, verpresster dosiseinheiten mit retardierter freisetzung und entsprechende dosiseinheit. |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
US5223268A (en) | 1991-05-16 | 1993-06-29 | Sterling Drug, Inc. | Low solubility drug-coated bead compositions |
EP0519144B1 (en) | 1991-06-21 | 1997-08-13 | Ilsan Ilac Ve Hammaddeleri Sanayi A.S. | New galenic process for omeprazole containing pellets |
SE9402422D0 (sv) | 1994-07-08 | 1994-07-08 | Astra Ab | New beads for controlled release and a pharmaceutical preparation containing the same |
FR2722984B1 (fr) | 1994-07-26 | 1996-10-18 | Effik Lab | Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees |
US5480330A (en) * | 1994-10-04 | 1996-01-02 | Outboard Marine Corporation | Marine propulsion pump with two counter rotating impellers |
US5545628A (en) * | 1995-01-10 | 1996-08-13 | Galephar P.R. Inc. | Pharmaceutical composition containing fenofibrate |
US5558879A (en) * | 1995-04-28 | 1996-09-24 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water soluble drugs in which a passageway is formed in situ |
DE19608750A1 (de) | 1996-03-06 | 1997-09-11 | Durachemie Gmbh & Co Kg | Verfahren zur Herstellung von Fenofibrat-Präparaten |
TR199802718T2 (xx) | 1996-06-28 | 1999-03-22 | Schering Corporation | Bir triazol mantara kar�� bile�i�ini i�eren a��zdan al�nan bile�im. |
FR2758461A1 (fr) | 1997-01-17 | 1998-07-24 | Pharma Pass | Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation |
FR2758459B1 (fr) | 1997-01-17 | 1999-05-07 | Pharma Pass | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation |
US6423517B2 (en) * | 1997-12-20 | 2002-07-23 | Genecor International, Inc. | Granule containing protein and salt layered on an inert particle |
US7101575B2 (en) * | 1998-03-19 | 2006-09-05 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly |
US6368620B2 (en) * | 1999-06-11 | 2002-04-09 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
US7863331B2 (en) * | 1999-07-09 | 2011-01-04 | Ethypharm | Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
FR2795961B1 (fr) | 1999-07-09 | 2004-05-28 | Ethypharm Lab Prod Ethiques | Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation |
JP2001089373A (ja) * | 1999-09-24 | 2001-04-03 | Tanabe Seiyaku Co Ltd | 経口投与製剤 |
US6667064B2 (en) * | 2000-08-30 | 2003-12-23 | Pilot Therapeutics, Inc. | Composition and method for treatment of hypertriglyceridemia |
EP1322289B1 (en) * | 2000-09-20 | 2007-07-25 | Jagotec AG | Spray drying process of compositions containing fenofibrate |
US8026281B2 (en) * | 2004-10-14 | 2011-09-27 | Lupin Atlantis Holdings, S.A. | Treating metabolic syndrome with fenofibrate |
DE602006001512D1 (de) * | 2006-04-20 | 2008-07-31 | Alcatel Lucent | Verfahren und Vorrichtung für effiziente gewichtete und gerechte Datenüberwachung |
-
2003
- 2003-10-03 US US10/677,861 patent/US7863331B2/en not_active Expired - Lifetime
-
2004
- 2004-10-01 CA CA2540235A patent/CA2540235C/en active Active
- 2004-10-01 EP EP08165521A patent/EP2000133A3/en not_active Withdrawn
- 2004-10-01 CN CNB2004800287311A patent/CN100544712C/zh active Active
- 2004-10-01 SI SI200431122T patent/SI1667666T1/sl unknown
- 2004-10-01 BR BRPI0414860A patent/BRPI0414860B8/pt active IP Right Grant
- 2004-10-01 AU AU2004277757A patent/AU2004277757B2/en active Active
- 2004-10-01 EP EP04769636A patent/EP1667666B9/en active Active
- 2004-10-01 NZ NZ546692A patent/NZ546692A/en unknown
- 2004-10-01 ES ES04769636T patent/ES2324670T3/es active Active
- 2004-10-01 JP JP2006530759A patent/JP5490354B2/ja active Active
- 2004-10-01 KR KR1020067006492A patent/KR101150235B1/ko active IP Right Grant
- 2004-10-01 AT AT04769636T patent/ATE428408T1/de active
- 2004-10-01 WO PCT/IB2004/003354 patent/WO2005032526A1/en active Application Filing
- 2004-10-01 MX MXPA06003656A patent/MXPA06003656A/es active IP Right Grant
- 2004-10-01 PL PL04769636T patent/PL1667666T3/pl unknown
- 2004-10-01 DK DK04769636T patent/DK1667666T3/da active
- 2004-10-01 PT PT04769636T patent/PT1667666E/pt unknown
- 2004-10-01 DE DE602004020641T patent/DE602004020641D1/de active Active
-
2006
- 2006-03-30 IL IL174660A patent/IL174660A/en active IP Right Grant
- 2006-05-03 NO NO20061960A patent/NO335933B1/no unknown
- 2006-05-03 ZA ZA200603504A patent/ZA200603504B/en unknown
- 2006-06-30 HK HK06107406.7A patent/HK1084895A1/xx unknown
-
2009
- 2009-06-30 CY CY20091100684T patent/CY1109929T1/el unknown
-
2010
- 2010-01-13 US US12/686,574 patent/US8529952B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1084895A1 (en) | Pharmaceutical composition containing fenofibrate and method for the preparation thereof | |
RS50035B (sr) | Farmaceutska kompozicija koja sadrži fenofibrat i postupak za njeno dobijanje | |
HRP20120136T1 (hr) | Imunogeni pripravak koji sadrži adjuvans | |
PL309721A1 (en) | Pharmaceutical composition containing fluoxetin hydrochloride | |
WO2007000778A3 (en) | Modified release pharmaceutical compositions on the basis of two polymers and processes thereof | |
AR018673A1 (es) | Derivados de 1,3-oxazolina y 1,3-tiazolina; procedimiento para su preparacion, composicion fitoprotectora, fungicida, insecticida acaricida nematocida y para la aplicacion en la proteccion de la madera o como agente de conservacion en masas de ... | |
RS52577B (en) | ONE-DAY OXYCODON FORMULATIONS | |
AR034900A1 (es) | Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica | |
BR0114392A (pt) | Formulação de vacina, método para produzir uma formulação de vacina, uso de uma preparação de vacina contra rsv dividido, kit para liberação de uma formulação de vacina intranasal, dispositivo de liberação intranasal, e, método para proteger ou tratar um mamìfero susceptìvel a, ou sofrendo de doença causada por rsv | |
NO971361D0 (no) | Fremgangsmåte for fremstilling av doseringsenheter ved våtgranulering | |
AU2002231889A1 (en) | Halogenated composition, method for preparing same and uses thereof | |
CA2136404A1 (fr) | Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale | |
IL124858A0 (en) | Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases | |
MXPA04003506A (es) | Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn. | |
WO2006048261A3 (en) | Oral solid dosage forms containing a low dose of estradiol | |
DK1305057T3 (da) | Mikropartikelformig biomaterialesammensætning af hyaluronsyre til medicinsk anvendelse | |
MY137570A (en) | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis crohn's disease | |
WO2010041908A3 (ko) | 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 신규한 용도 | |
PT991409E (pt) | Composicoes farmaceuticas de libertacao controlada contendo tiagabina | |
HK1055675A1 (en) | Method for stabilizing a pharmaceutical preparation | |
BR0210063A (pt) | Composição estável e uso da mesma | |
DE69501183D1 (de) | Feste orale pharmazeutische Zubereitung mit Gemfibrozil als aktiver Inhaltsstoff und Verfahren zur Herstellung | |
CN106551839A (zh) | 一种美白眼膜及其制备方法 | |
RS20060413A (en) | Non-disintegrating oral solid composition of high dose of water soluble drugs | |
SK5892Y1 (sk) | Herbal formulation and extract thereof |